Bloomberg's Michelle Davis joins Dani Burger on "Bloomberg Deals." Gilead (GILD) agreed to buy private German biotech Tubulis in a deal worth up to $5 billion as it looks to boost its portfolio in a hot new area of cancer drug development.

Bloomberg videos, provided by MT Newswires